[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_2998 

# __Limited data, efficacy__

## Category to which it belongs

* [The challenges include disintegrated and non-interoperable data, limited data access, data quality issues, and lack of standardized data sharing.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_101.md)

## Closest similar item

* [Absence of efficacy studies in clinical settings](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1367.md)
* [Limited data and sample size](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1661.md)
* [Limited data](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3411.md)
* [Limited data, accuracy](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2997.md)
* [Data gaps, limited research effect](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2623.md)
* [Limited testing and treatment capabilities](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2826.md)
* [Insufficient data for analysis](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3206.md)
* [Limited statistical significance](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3383.md)
* [Lack of patient control over medical data](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_321.md)
* [Limited sample size in observational studies](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_814.md)

## Mitigations of this risk

* [Vaccine development and drug discovery](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_1255.md)

